UK Companies House feature
CERTARA UK LIMITED
Cash
£28M
+59.8% vs 2021
Net assets
£97M
+29.8% vs 2021
Employees
230
+21.7% vs 2021
Profit before tax
£23M
+35.3% vs 2021
Profile
- Company number
- 04217235
- Status
- Active
- Incorporation
- 2001-05-15
- Last accounts made up
- 2024-12-31
- Account category
- FULL
- Primary SIC
- 63110
Net assets
5-year trend · vs UK AI & Enterprise SaaS median
Accounts
5-year trend · latest 2022-12-31
| Metric | Trend | 2018-12-31 | 2019-12-31 | 2020-12-31 | 2021-12-31 | 2022-12-31 |
|---|---|---|---|---|---|---|
| Turnover | — | — | £34,151,635 | £38,549,351 | £46,044,700 | |
| Operating profit | — | — | £13,834,336 | £15,393,445 | £21,431,253 | |
| Profit before tax | — | — | £16,072,047 | £17,250,336 | £23,335,245 | |
| Net profit | — | — | £12,805,028 | £13,523,626 | £18,391,090 | |
| Cash | — | — | £7,270,769 | £17,708,006 | £28,295,607 | |
| Total assets less current liabilities | — | — | £59,452,819 | £75,312,434 | £97,619,255 | |
| Net assets | — | — | £58,807,678 | £74,874,016 | £97,216,860 | |
| Equity | £33,153,664 | £45,004,119 | £58,807,678 | £74,874,016 | £97,216,860 | |
| Average employees | — | — | 171 | 189 | 230 | |
| Wages | — | — | £12,819,615 | £16,093,560 | £19,781,491 |
Values shown as filed in iXBRL accounts. — indicates the figure was not present in the extracted filing (either not filed under that concept or absent from the period). About these numbers
Audit & accounting basis
From AI-extracted PDF accounts
- Accounting basis
- FRS 102
- Reporting scope
- Standalone (parent only)
- Auditor
- RSM UK Audit LLP
- Audit opinion
- Unqualified (clean)
- Going concern
- Affirmed
“At the time of approving the financial statements, the directors have a reasonable expectation that the Company has adequate resources to continue in operational existence for the foreseeable future. Thus the directors continue to adopt the going concern basis of accounting in preparing the financial statements.”
Subsidiaries
- Insight Medical Writing Limited · 100% held · England and Wales
- Formedix Limited · 100% held · England and Wales
- Insight PV & Consulting GmbH · 100% held · Deutschland
- Certara G.K. · 100% held · Japan
- Certara Korea Ltd · 100% held · Republic of Korea
- Chemaxon Ktf · 100% held · US
- Chemaxon, LLC · 100% held · US
- Chemaxon GmbH · 100% held · Switzerland
- Chemaxon Limited · 100% held · England and Wales
Significant events
- “The company purchased the Chemaxon subsidiaries, in October 2024, for £73 million in cash which was funded by way of an intercompany loan with Certara USA.”
- “During the current year, the Company made a significant investment by acquisition of Chemaxon for $90 million in cash which was finalised on October 1, 2024.”
Auditor / going-concern / subsidiary information is extracted from the PDF version of the latest annual accounts and is not tagged in iXBRL. About these numbers
People
4 active · 23 resigned
| Name | Role | Appointed | Born | Nationality |
|---|---|---|---|---|
| CORCORAN, Daniel Desmond | Secretary | 2024-06-28 | — | — |
| ASPBURY, Robert Allen, Dr | Director | 2020-01-01 | May 1971 | British |
| CORCORAN, Daniel Desmond | Director | 2024-07-08 | Dec 1966 | American |
| WILSON, Richard James | Director | 2016-11-01 | Feb 1971 | British |
Show 23 resigned officers
| Name | Role | Appointed | Resigned |
|---|---|---|---|
| BIRTLES, Richard Mark | Secretary | 2001-05-15 | 2012-02-29 |
| DEIESO, Donald Allan | Secretary | 2013-12-19 | 2017-08-15 |
| LEFKOWITZ, Alan | Secretary | 2014-12-29 | 2018-06-20 |
| MUNN, James | Secretary | 2012-02-29 | 2013-12-18 |
| TRAYNOR, Richard | Secretary | 2018-06-20 | 2024-05-31 |
| YORK PLACE COMPANY SECRETARIES LIMITED | Corporate Nominee Secretary | 2001-05-15 | 2001-05-15 |
| CATTON, David John, Mr. | Director | 2001-05-15 | 2012-02-29 |
| DEIESO, Donald Allan | Director | 2013-12-18 | 2017-08-15 |
| EVANS, John William | Director | 2002-05-09 | 2012-02-29 |
| FEEHERY, William Francis | Director | 2019-06-28 | 2023-06-01 |
| HOPKINS, James Lee | Director | 2012-02-29 | 2014-04-01 |
| LEFKOWITZ, Alan | Director | 2017-08-15 | 2018-06-20 |
| MUNIZ, Edmundo Manuel | Director | 2017-08-15 | 2019-03-31 |
| MUNN, James | Director | 2014-12-29 | 2016-11-01 |
| MUNN, James | Director | 2012-02-29 | 2013-12-18 |
| ROSTAMI-HOCHAGHAN, Amin, Dr | Director | 2002-05-09 | 2012-02-29 |
| SCHEMICK, Michael Andrew | Director | 2014-12-29 | 2023-03-24 |
| TOON, Stephen, Dr. | Director | 2015-12-07 | 2020-01-01 |
| TOON, Stephen, Dr. | Director | 2006-09-14 | 2012-02-29 |
| TRAYNOR, Richard Michael | Director | 2023-06-01 | 2024-05-31 |
| TUCKER, Geoffrey Thomas, Dr | Director | 2002-05-09 | 2012-02-29 |
| YINGLING, John | Director | 2012-02-29 | 2014-12-29 |
| YORK PLACE COMPANY NOMINEES LIMITED | Corporate Nominee Director | 2001-05-15 | 2001-05-15 |
Ownership
Persons with significant control
| Name | Kind | Nature of control | Notified | Status |
|---|---|---|---|---|
| Mr Terrence Mullen | Individual | Shares 75–100%, Voting 75–100%, Appoints directors | 2016-04-06 | Ceased 2016-04-06 |
| Jeffrey Kovach | Individual | Shares 75–100%, Voting 75–100%, Appoints directors | 2016-04-06 | Ceased 2016-04-06 |
| Certara Uk Holdings Limited | Corporate entity | Shares 75–100%, Voting 75–100%, Appoints directors | 2016-04-06 | Active |
Filing timeline
Last 20 of 172 total filings
| Date | Type | Category | Description |
|---|---|---|---|
| 2025-10-04 | AA | accounts | accounts with accounts type full |
| 2025-05-19 | CS01 | confirmation-statement | confirmation statement with no updates |
| 2024-10-13 | AA | accounts | accounts with accounts type full |
| 2024-08-15 | RP04AP03 | officers | second filing of secretary appointment with name |
| 2024-07-17 | RP04AP01 | officers | second filing of director appointment with name |
| 2024-07-09 | AP01 | officers | appoint person director company with name date |
| 2024-07-09 | AP03 | officers | appoint person secretary company with name date |
| 2024-07-01 | TM01 | officers | termination director company with name termination date |
| 2024-07-01 | TM02 | officers | termination secretary company with name termination date |
| 2024-05-20 | CS01 | confirmation-statement | confirmation statement with no updates |
| 2023-07-19 | AA | accounts | accounts with accounts type full |
| 2023-06-09 | TM01 | officers | termination director company with name termination date |
| 2023-06-09 | AP01 | officers | appoint person director company with name date |
| 2023-05-23 | CS01 | confirmation-statement | confirmation statement with no updates |
| 2023-05-09 | AD02 | address | change sail address company with old address new address |
| 2023-04-11 | TM01 | officers | termination director company with name termination date |
| 2022-09-28 | AA | accounts | accounts with accounts type full |
| 2022-05-16 | CS01 | confirmation-statement | confirmation statement with no updates |
| 2021-12-10 | AA | accounts | accounts with accounts type full |
| 2021-05-17 | CS01 | confirmation-statement | confirmation statement with no updates |
Credit score
Altman Z″ (private-firm) · reference 2022-12-31
12.40
SAFE
Altman Z″
- Working capital / Total assets 0.715 × 6.56 = +4.69
- Retained earnings / Total assets 0.000 × 3.26 = +0.00
- EBIT / Total assets 0.190 × 6.72 = +1.27
- Book equity / Total liabilities 6.124 × 1.05 = +6.43
Bands: > 2.6 safe · 1.1–2.6 grey · < 1.1 distress. Z″ is a public-formula baseline, not a substitute for adverse-data signals (CCJs, charges, gazette notices) — those land in a later pass.
Activity Score
Filings velocity, capital events, officer churn, accounts trajectory